Analyst Moves: ABT, ACN, EFX, JCP

Goldman Sachs (GS) upgraded shares of Abbott Labratories (ABT) from neutral to buy citing growth of margin expansion. Additionally Goldman upgraded Accenture (ACN) shares to buy placing a $90 target price. On Friday, Accenture (ACN) announced they are buying Acquity Group Ltd. (AQ), a leading digital marketing and eCommerce company.